MAGE-A1, MAGE-A3, NY-ESO-1 peptides vaccine

{
  "id": "MLC-T-ONC-014966",
  "term": "MAGE-A1, MAGE-A3, NY-ESO-1 peptides vaccine",
  "field": "Oncology and biomedicine",
  "definition": "A cancer vaccine comprised of synthetic peptides derived from human melanoma antigen A1 (MAGE-A1), human melanoma antigen A3 (MAGE-A3) and cancer-testis antigen NY-ESO-1 with potential immunostimulating and antineoplastic activities. Upon administration, MAGE-A1/MAGE-A3/NY-ESO-1 peptides vaccine may stimulate the immune system to mount a cytotoxic T-cell (CTL) response against tumor cells expressing MAGE-A1, MAGE-A3 and NY-ESO-1, resulting in tumor cell lysis. The MAGE-A1, MAGE-A3, and NY-ESO-1 tumor-associated antigens (TAAS) are overexpressed by a variety of cancer cell types.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/mage-a1-mage-a3-ny-eso-1-peptides-vaccine/"
}